Comparison of Piezoelectric Split-crest Technique Versus Expansion Using Hand Driven Ridge Expanders in Treatment of Maxillary Narrow Ridges

• Sponsor: ahmed ashraf abdelreheem (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT05141331
• Collaborator: (none)
• Enrollment: 28
• Location: 1
• Arms: 2
• Anticipated Duration (Months): 13.4
• Patients Per Site Per Month: 2.1

Study Details

Study Description

Brief Summary

Comparison of Piezoelectric split-crest technique versus expansion using Hand Driven Ridge Expanders in treatment of Maxillary Narrow Ridges

Condition or Disease	Intervention/Treatment	Phase
Edentulous Alveolar Ridge	Device: piezoelectric	N/A

Study Design

• Study Type: Interventional
• Anticipated Enrollment: 28 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: Double (Participant, Outcomes Assessor)
• Primary Purpose: Treatment
• Official Title: Comparison of Piezoelectric Split-crest Technique Versus Expansion Using Hand Driven Ridge Expanders in Treatment of Maxillary Narrow Ridges
• Actual Study Start Date: May 20, 2021
• Anticipated Primary Completion Date: May 1, 2022
• Anticipated Study Completion Date: Jul 1, 2022

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Piezoelectric split-crest technique in treatment of Maxillary Narrow Ridges Piezoelectric split-crest technique in treatment of Maxillary Narrow Ridges	Device: piezoelectric; Comparing Piezoelectric split-crest technique versus expansion using Hand Driven Ridge Expanders in treatment of Maxillary Narrow Ridges
Active Comparator: Hand Driven Ridge Expanders in treatment of Maxillary Narrow Ridges Hand Driven Ridge Expanders in treatment of Maxillary Narrow Ridges	Device: piezoelectric; Comparing Piezoelectric split-crest technique versus expansion using Hand Driven Ridge Expanders in treatment of Maxillary Narrow Ridges

Outcome Measures

Primary Outcome Measures

1. bone width [5 months]

   bone width gain in millimeters

Secondary Outcome Measures

1. implant stability [5 months]

   implant stability measured with periotest

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 70 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• Participants are free from any systemic diseases.

• Participant have missing one or two premolars or molars with sufficient alveolar ridge height and insufficient alveolar ridge buccolingual (BL) width that interfere with conventional straight forward implant placement.

• The minimum BL ridge width included in the study will be 3.5 mm to facilitate ridge splitting and expansion

Exclusion Criteria:

• Patients with residual infections in the edentulous areas.

• Medically compromised groups.

• Smokers and patients with poor oral hygiene.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Cairo University	Giza		Egypt

Sponsors and Collaborators

• ahmed ashraf abdelreheem

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: ahmed ashraf abdelreheem, assistant lecturer, Cairo University
• ClinicalTrials.gov Identifier: NCT05141331
• Other Study ID Numbers: 27721
• First Posted: Dec 2, 2021
• Last Update Posted: Dec 3, 2021
• Last Verified: Dec 1, 2021

• Individual Participant Data (IPD) Sharing Statement: Undecided
• Plan to Share IPD: Undecided
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Mouth, Edentulous

Study Results

No Results Posted as of Dec 3, 2021